Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
JMS CoTSE:7702 +1.32%62 Beneish M-Score is -2.60 as of Jul. 30, 2026. GuruFocus rates TSE:7702 with a GF Score™ of 62/100 and a GF Value™ of 円469.13 (Fairly Valued). The stock has 10 warning signs investors should review. Among 761 Medical Devices & Instruments companies, JMS Co ranks better than 52.56% on this metric.
The zones of discrimination for M-Score is as such:
An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.
Good Sign:
Beneish M-Score -2.6 no higher than -1.78, which implies that the company is unlikely to be a manipulator.
The historical rank and industry rank for JMS Co's Beneish M-Score or its related term are showing as below:
TSE:7702'
s Beneish M-Score Range Over the Past 10 Years
Min: -2.72 Med: -2.59 Max: -2.5
Current: -2.6
During the past 13 years, the highest Beneish M-Score of JMS Co was -2.50. The lowest was -2.72. And the median was -2.59.
JMS Co Beneish M-Score Related Terms
JMS Co Beneish M-Score Historical Data
* Premium members only.
The historical data trend for JMS Co's Beneish M-Score can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSE:7702 vs ISRG, BDX, MDLN: Beneish M-Score Comparison
For the Medical Instruments & Supplies subindustry, JMS Co's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
JMS Co Beneish M-Score vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, JMS Co's Beneish M-Score distribution charts can be found below:
* The bar in red indicates where JMS Co's Beneish M-Score falls into.
The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.
The M-Score Variables:
The M-score of JMS Co for today is based on a combination of the following eight different indices:
M
=
-4.84
+
0.92 * DSRI
+
0.528 * GMI
+
0.404 * AQI
+
0.892 * SGI
+
0.115 * DEPI
=
-4.84
+
0.92 * 1.0604
+
0.528 * 0.979
+
0.404 * 1.0623
+
0.892 * 0.944
+
0.115 * 0.9939
-
0.172 * SGAI
+
4.679 * TATA
-
0.327 * LVGI
-
0.172 * 1
+
4.679 * -0.028495
-
0.327 * 1.0073
=
-2.60
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.
DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.
DEPI
=
(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1))
/
(Depreciation_t / (Depreciaton_t + PPE_t))
=
(3888 / (3888 + 28291))
/
(3833 / (3833 + 27698))
=
0.120824
/
0.121563
=
0.9939
Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.
6. SGAI = Sales, General and Administrative expenses Index
Total accruals calculated as the change in working capital accounts other than cash less depreciation.
TATA
=
(IncomefromContinuingOperations_t
-
CashFlowsfromOperations_t)
/
TotalAssets_t
=
(NetIncome_t - NonOperatingIncome_t
-
CashFlowsfromOperations_t)
/
TotalAssets_t
=
(-783 - 0
-
1584)
/
83067
=
-0.028495
An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.
JMS Co has a M-score of -2.60 suggests that the company is unlikely to be a manipulator.
JMS Co (TSE:7702) has a Beneish M-Score of -2.60 as of Jul. 30, 2026. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on JMS Co and its competitors. According to the industry distribution chart, JMS Co ranks #361 out of 761 companies in the Medical Devices & Instruments industry, placing it in the top 47.4%.
Is JMS Co's Beneish M-Score too high?
JMS Co's current Beneish M-Score is -2.60. Based on the distribution chart, JMS Co ranks #361 out of 761 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, JMS Co has a GF Score™ of 62/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does JMS Co's Beneish M-Score compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, JMS Co ranks #361 out of 761 companies for Beneish M-Score. This puts JMS Co in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beneish M-Score for a Medical Devices & Instruments company?
A good Beneish M-Score depends on the Medical Devices & Instruments industry context. However, Beneish M-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beneish M-Score mean?
A high Beneish M-Score can signal that a stock is expensive relative to its fundamentals. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on JMS Co and its competitors. JMS Co's current Beneish M-Score is -2.60. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is JMS Co stock overvalued right now?
Based on GuruFocus' analysis, JMS Co (TSE:7702) is currently considered Fairly Valued. The stock's GF Value™ is 円469.13, compared to a current price of 円459.00 — trading 2.2% below its estimated fair value. The current Beneish M-Score is -2.60. JMS Co's overall GF Score™ is 62/100 with 10 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beneish M-Score calculated?
Beneish M-Score is calculated from a company's financial statements. For JMS Co (TSE:7702), the current Beneish M-Score is -2.60 as of Jul. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is JMS Co (TSE:7702) Overvalued in 2026?
Based on GuruFocus' analysis, JMS Co stock appears to be undervalued.
The current stock price of 円459.00 is trading 2.2% below its estimated GF Value™ of 円469.13.
GuruFocus considers JMS Co to be Fairly Valued.
Key valuation signals for TSE:7702:
Beneish M-Score: -2.60
GF Value™: 円469.13 vs. price of 円459.00 (2.2% below fair value)
No single metric tells the full story. See the TSE:7702 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
JMS Co Ltd is a Japan-based medical equipment manufacturer. The company is engaged in the manufacture, sale, export, and import of medical equipment and pharmaceuticals. Products offered by the company include an infusion pump, syringe pump, surgical gown, peritoneal dialysate, dialyzer, mask cap, sheet for treatment, pacemaker, heat exchanger, blood bag, among others. JMS has network operations in various countries including Europe, North America, Asia, the Middle East, Latin America and Africa.
62GF Score
Get the complete analysis for TSE:7702
Beneish M-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:7702 has been successfully added to your 
